DIGOXIN tablet indications and usage: Difference between revisions
Created page with "__NOTOC__ {{Digoxin}} {{CMG}}; {{AE}} {{AK}} '''''For patient information about Digoxin immune fab, click here.''''' ==1 INDICATIONS AND US..." |
|||
| Line 11: | Line 11: | ||
Digoxin Tablets, USP are indicated for the treatment of mild to moderate[[ heart failure]] in adults. Digoxin Tablets, USP increase left ventricular [[ejection fraction]]and improve heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, Digoxin Tablets, USP should be used in combination with a [[diuretic]] and an [[angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme (ACE) inhibitor]].. | Digoxin Tablets, USP are indicated for the treatment of mild to moderate[[ heart failure]] in adults. Digoxin Tablets, USP increase left ventricular [[ejection fraction]]and improve heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, Digoxin Tablets, USP should be used in combination with a [[diuretic]] and an [[angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme (ACE) inhibitor]].. | ||
1.2 Heart Failure in Pediatric Patients | ===1.2 Heart Failure in Pediatric Patients=== | ||
Digoxin Tablets, USP increase myocardial contractility in pediatric patients with [[heart failure]]. | Digoxin Tablets, USP increase myocardial contractility in pediatric patients with [[heart failure]]. | ||
1.3 Atrial Fibrillation in Adults | ===1.3 Atrial Fibrillation in Adults=== | ||
Digoxin Tablets, USP are indicated for the control of ventricular response rate in adult patients with chronic [[atrial fibrillation]]. | Digoxin Tablets, USP are indicated for the control of ventricular response rate in adult patients with chronic [[atrial fibrillation]]. | ||
Revision as of 11:52, 28 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
For patient information about Digoxin immune fab, click here.
1 INDICATIONS AND USAGE
1.1 Heart Failure in Adults
Digoxin Tablets, USP are indicated for the treatment of mild to moderateheart failure in adults. Digoxin Tablets, USP increase left ventricular ejection fractionand improve heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, Digoxin Tablets, USP should be used in combination with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor..
1.2 Heart Failure in Pediatric Patients
Digoxin Tablets, USP increase myocardial contractility in pediatric patients with heart failure.
1.3 Atrial Fibrillation in Adults
Digoxin Tablets, USP are indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation.
References
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41c16cff-b03e-405e-a617-d6f45d3ce2bd